HELPTAG:MinRegistration_TopMessage

Nov 9, 2011

To access all AuntMinnieEurope.com content create a free account now:

Latest in Clinical News
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
Low muscle density on coronary CT linked to heart risk
June 30, 2026
Mri Scanner2 400
Medneo acquires Ramsay Diagnostics UK mobile imaging fleet
June 30, 2026
Business Deal Corporate 400
Ratio Therapeutics signs Ac-225 supply agreement with PanTera
June 30, 2026
Ai Logo
GE HealthCare offers upgrades for interventional systems
June 29, 2026
Related Stories
75x75 Am Logo Nav
Companies
AuntMinnieEurope.com
2011 11 09 14 43 06 952 Liverpool 70
Medical, Legal, and Practice
Off-label use merits attention in interventional radiology
2011 11 09 14 49 40 803 Katharina Bider 150
Clinical News
Swiss MSK radiologist wins iPad draw
2011 11 09 10 02 55 619 Eu Flag 70
Clinical News
New threat emerges to clinical MRI in Europe
More in Clinical News
Low muscle density on coronary CT linked to heart risk
By Will Morton
Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
Medneo acquires Ramsay Diagnostics UK mobile imaging fleet
By AuntMinnieEurope.com staff writers
Medneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.
June 30, 2026
Mri Scanner2 400
Ratio Therapeutics signs Ac-225 supply agreement with PanTera
By AuntMinnie.com staff writers
Deal will support Ratio's alpha therapy programs.
June 30, 2026
Business Deal Corporate 400
GE HealthCare offers upgrades for interventional systems
By AuntMinnie.com staff writers
Upgraded systems also qualify for GE HealthCare's Tube Watch and OnWatch Predict service options.
June 29, 2026
Ai Logo
Fujifilm, IAEA sign agreement to expand cancer imaging
By AuntMinnie.com staff writers
The two organizations will collaborate on awareness campaigns, education and training programs for healthcare professionals, and the provision of Fujifilm medical equipment.
June 29, 2026
Acquisitions
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
By AuntMinnieEurope.com staff writers
Imaging focuses on the mid-trimester anomaly scan.
June 26, 2026
Image2
Novel SST2-PET tracer shows promise in patients with NETs
By Will Morton
With a half-life of 3.3 hours, cyclotron-produced Cu-61 NODAGA-LM3 could allow delayed imaging and centralized distribution.
June 25, 2026
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
PET RANO gains visibility as neurotheranostics research advances
By Claudia Tschabuschnig
Standardized PET response assessment, emerging theranostic targets, and new strategies to overcome the blood-brain barrier are among the developments shaping neuro-oncology research.
June 24, 2026
Prof. Nathalie Albert of Ludwig Maximilian University of Munich, member of the EANM Oncology & Theranostics Committee and Scientific Chair of the NMN Symposium.
As theranostics advances, access challenges remain across Europe
By Claudia Tschabuschnig
Theranostics is advancing rapidly, but access remains uneven across Europe. According to Prof. Clemens Decristoforo, differences in national regulations and healthcare systems continue to influence patient access to innovative radiopharmaceuticals.
June 24, 2026
Prof. Clemens Decristoforo is a member of the EANM Policy & Regulatory Affairs Council and professor at the Department of Nuclear Medicine at the Medical University of Innsbruck.
BrightHeart receives CE mark for prenatal ultrasound AI platform
By AuntMinnieEurope.com staff writers
The CE mark follows an €11 million series A funding round.
June 24, 2026
Ai2
Six European societies launch RLT Referral Pathways Project
By Claudia Tschabuschnig
Radioligand therapy has proven itself clinically for advanced prostate cancer. What hasn't caught up is Europe's healthcare infrastructure.
June 23, 2026
Radiology and nuclear medicine are converging on clinical audit and quality frameworks across Europe.
DRGEM wins CE certification for mobile DR system
By AuntMinnie.com staff writers
The certification follows U.S. Food and Drug Administration clearance for Raymo in May.
June 22, 2026
Approval
Page 1 of 1325
Next Page